Is Immunic Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: IMUX) stock is to Buy IMUX stock.
Out of 2 analysts, 0 (0%) are recommending IMUX as a Strong Buy, 1 (50%) are recommending IMUX as a Buy, 1 (50%) are recommending IMUX as a Hold, 0 (0%) are recommending IMUX as a Sell, and 0 (0%) are recommending IMUX as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year IMUX price target, the average IMUX price target is $5.00, with the highest IMUX stock price forecast at $5.00 and the lowest IMUX stock price forecast at $5.00.
On average, Wall Street analysts predict that Immunic's share price could reach $5.00 by Jan 31, 2024. The average Immunic stock price prediction forecasts a potential upside of 237.84% from the current IMUX share price of $1.48.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.